Skip to the page

Data / Medical devices / United States / Baxter Healthcare Corporation

Baxter Healthcare Corporation: FDA-registered device maker in Hayward, CA, United States, 3 PMA approvals

Baxter Healthcare Corporation is registered with the FDA (registration 2937398) in Hayward, CA, United States. It lists 4 device types. The FDA files 3 PMA approvals under its listings, the newest dated March 1, 2013. 1 recall event names it as the recalling firm. Registered through 2026. FDA data exported November 3, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
2937398
Address
21026 Alexander Court, Hayward, CA, United States, 94545
Owner or operator
BAXTER HEALTHCARE CORPORATION (1417572)
Roles
Manufacturer
First device listed
July 3, 2007
Registered through
2026
Brand names listed
ARS-530 Air Regulator System, Coseal Surgical Sealant, EasySpray, Floseal, PreveLeak

Devices it lists

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
March 1, 2013P100030ARTERX SURGICAL SEALANTNBE18July 10, 2025accessdata.fda.gov
December 12, 2003P030039COSEAL SURGICAL SEALANTNBE28December 18, 2025accessdata.fda.gov
December 8, 1999P990009FLOSEAL MATRIX/FLOSEAL MATRIX HEMOSTATIC SEALANT/PROCEED HEMOSTATIC SEALANTPMX74November 13, 2025accessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
May 12, 201674139Class IITerminatedCOSEAL Surgical Sealant Kit, 2 mL, Product Code: 934070; For use in vascular reconstructions to achieve adjunctive hemostasis by mechanically sealing areas of leakage.Potential for incomplete dissolution of the polyethylene glycol (PEG) component during the reconstitution of the product, which may affect the consistency of the hydrogel formation during use.accessdata.fda.gov

Compare with other makers

Updated July 10, 2025. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.